Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing

The Lead

Malaria Vaccine is a Letdown But Could Still Reduce Cases

April 24, 2015 | by MARIA CHENG, AP Medical Writer | News | Comments

The world's leading malaria vaccine candidate appears to be a disappointment, with final study results showing it doesn't work very well and that initial protection fades over time.

TOPICS:
View Sample

FREE Daily Email Newsletter

GW Pharmaceuticals Receives Orphan Drug Designation For Cannabidiol Treatment of Neonatal Hypoxic-Ischemic Encephalopathy

April 24, 2015 11:15 am | by Globe Newswire | News | Comments

There are currently no FDA-approved medicines specifically indicated for NHIE.

TOPICS:

Pipeline Advancements And Asset Acquisitions Fueled Mid-Cap Biotech R&D in 2014

April 24, 2015 11:09 am | by Global Data | News | Comments

The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spenders Regeneron and Vertex, says research and consulting firm GlobalData.

TOPICS:

Hospira Recalls One Lot Of Bupivacaine HCl Injection

April 24, 2015 11:02 am | by U.S. Food And Drug Administration | News | Comments

Hospira is issuing a voluntary recall of one lot of Preservative-Free Bupivacaine HCl Injection, USP, 0.5% (5 mg/mL), 30 mL Single-dose (NDC: 0409-1162-02, Lot 38-515-DK, Expiry 1FEB2016) due to one confirmed customer complaint of orange and black, visible particles embedded and free floating within a single-dose glass teartop vial.

TOPICS:
Advertisement

Aseptic, Glass-Free Injectable Platform

April 24, 2015 10:49 am | by Catalent | Product Releases | Comments

Catalent (Booth 1546) announced the launch of ADVASEPT Lock, a stopper-less, glass- and needle-free vial for the safe and efficient delivery of injectable medications.

TOPICS:

Divestment Gains Boost Net Earnings at Novartis

April 23, 2015 4:48 pm | by The Associated Press | News | Comments

Swiss-based pharmaceutical company Novartis reported a large jump in first-quarter net profit Thursday as it recorded one-time gains from deals with other drug companies.

TOPICS:

Catalent Awarded Grant as Part of a Vaccine Research Consortium

April 23, 2015 10:45 am | by Catalent | News | Comments

Catalent announced that it has received a significant project grant as part of a consortium looking to evaluate, develop and manufacture thermo stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates.

TOPICS:

INTERPHEX Day Two Wrapup

April 23, 2015 10:34 am | by Advantage Business Media | Videos | Comments

Can't make it to INTERPHEX? We've got you covered with a summary of the hot topics circulating the conference.

TOPICS:

Mylan Launches Generic Sofosbuvir Tablets, MyHep, in India

April 23, 2015 10:30 am | by PRNewswire | News | Comments

The product is indicated for the treatment of chronic hepatitis C, a blood-borne infectious disease that affects more than 100 million people in the developing world, including approximately 12 million people in India.

TOPICS:
Advertisement

Oral Therapies The Next Step For Rheumatoid Arthritis

April 23, 2015 10:22 am | by Frost & Sullivan | News | Comments

The market for other rheumatoid arthritis therapeutics is considerable as many patients do not respond well to TNF inhibitors.

TOPICS:

McCormack Pharma's Discovery Could Mean New Guidelines For Anti-Platelet Drug Use

April 23, 2015 10:16 am | by PRNewswire | News | Comments

Clopidogrel (Plavix) is an anti-platelet drug that is used to prevent the formation of a thrombus (clot) in vulnerable patients. However, a significant proportion of patients who receive clopidogrel remain at risk for subsequent death, myocardial infarction, stent thrombosis, and stroke because of insufficient clopidogrel-induced platelet inhibition.

TOPICS:

Study: Drug Successfully Treats Ebola Strain

April 23, 2015 10:07 am | by Andy Szal, Digital Reporter | News | Comments

Researchers then gave the TKM-Ebola-Makona drug to three of the monkeys, each of whom developed milder symptoms and fully recovered from the disease.

TOPICS:

Pfizer Says Leukemia Drug Met 1 Goal in Study

April 22, 2015 5:03 pm | by The Associated Press | News | Comments

Pfizer said that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.

TOPICS:

With Bird Flu Spreading, USDA Starts on Potential Vaccine

April 22, 2015 5:00 pm | by STEVE KARNOWSKI, Associated Press | News | Comments

The U.S. Department of Agriculture is working on a vaccine to counter a deadly strain of bird flu, as losses to poultry producers mount.

TOPICS:

INTERPHEX Pic of The Day

April 22, 2015 11:44 am | by Advantage Business Media | News | Comments

FETTE Compacting's Patrice Gesner poses with their Editor's Choice INTERPHEX Exhibitor Award.

TOPICS:

Capricor Granted FDA Orphan Drug Designation For Allogeneic Cardiosphere-Derived Cells

April 22, 2015 11:28 am | News | Comments

Capricor Therapeutics, Inc. today announced that it has been granted orphan drug designation by FDA for its cell therapeutic product candidate, CAP-1002, for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy (DMD).

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading